Clinical Trial Update: Long-term Clinical Study of CN128 in Thalassemia With Sever Liver Iron Overloaded Patients [Phase 2]

View source ↗

Summary

An update on the Phase 2 long-term study of CN128 in patients with thalassemia and severe liver iron overload, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Overload
• Thalassemia

Drugs mentioned

• CN128

Snippet

Sponsor: Hangzhou Zede Pharma-Tech Co., Ltd. | Conditions: Thalassemia, Iron Overload | Phase 2 | Status: COMPLETED